Cesarean Myomectomy; Five Years Experience of a Tertiary Center

Abstract

INTRODUCTION: Uterine fibroids are the most common benign tumor of the genital tract among women. Our objective in this study is to evaluate the effect of myoma size on the clinical outcomes of patients by retrospectively examining the files of patients who underwent myomectomy during cesarean section in our clinic. METHODS: In this study, files of 65 patients who underwent myomectomy during cesarean section in Van Yuzuncu Yil University Gynecology and Obstetrics Clinic between January 2016 and January 2021 were analyzed retrospectively. Patients were divided into 2 groups, according to the size of uterine fibroids, as Group1, consisting of patients with the size of a uterine fibroid of<5 cm, and Group2, consisting of patients with the size of a uterine fibroid of ≥5 cm RESULTS: There was no significant difference between the groups in terms of age, parity, abortion history, gestational week, preoperative hemoglobin levels, durations of operation, and hospitalization duration. The postoperative hemoglobin value of Group1 was significantly higher than Group2 (10.67+-1.34 g/dL and 9.84+-1.38 g/dL, respectively; p=0.017). DISCUSSION AND CONCLUSION: Our study demonstrates that the amount of bleeding and the need for transfusion increase with the increase in the size of the myoma. We consider that performing myomectomy during CS would assist in reducing the need for myomectomy or hysterectomy in the future. Based on the above-mentioned reasons, the results of our study support cesarean myomectomy in terms of cost-effectiveness.

Keywords

• myomectomy
• cesarean myomectomy
• blood transfusion